drug prices

Mylan CEO Heather Bresch defended pricing for the company's EpiPen on Capitol Hill in September.

Mylan To Sell Generic EpiPen At Half The Price Of Original

5:36pm December 16, 2016

by Alison Kodjak

Drugmaker Mylan is launching a generic version of its own EpiPen. The lower price could quiet criticism about the high cost of the brand-name anti-allergy drug. There's also a business twist.

West Virginia Grapples With High Drug Costs

5:04pm October 15, 2016

by Kara Lofton

Climbing drug prices are taking a toll on West Virginia's budget, some state legislators say. Expensive drugs fuel an increase in Medicaid spending, which leaves less money for schools and roads.

Mylan CEO Claims EpiPens Aren't As Profitable As Everyone Thinks

4:30pm September 21, 2016

by Alison Kodjak

In testimony prepared for a congressional hearing, Mylan CEO Heather Bresch says the company makes about $50 in profit on each EpiPen. Analysts say it's still a hefty margin.

How big a deal is the spending on drugs for rare diseases?

How Much Do Drugs For Rare Diseases Add To Health Care Spending?

4:16pm September 07, 2016

by Sarah Jane Tribble

Researchers analyzing recent drug spending in the U.S. say that high-priced drugs for rare diseases aren't having a widespread or significant effect on overall health care spending.

The cost of an EpiPen two-pack has risen more than 400 percent in recent years. The drug is used to halt severe allergic reactions.

Discounts Aren't Enough to Halt Outrage At High EpiPen Prices

6:28pm August 25, 2016

by Alison Kodjak

EpiPen, the new poster child for prescription drug price gouging, may find that offering discount coupons isn't enough to mollify its critics in Congress and online.

Queue Listen Now

Tighter Patent Rules Could Help Lower Drug Prices, Study Shows

11:44am August 23, 2016

by Alison Kodjak

Repeated extensions of drug patents help fend off competitors, researchers say, keeping prices high. And the fact that Medicare and Medicaid can't negotiate for discounts doesn't help, either.

Treatment for age-related macular degeneration requires injections in the eyeball.

How A Cancer Drug Has Saved People From Going Blind

3:02pm May 06, 2016

by Julie Rosenthal

Ten years ago, there wasn't much doctors could do to keep people with age-related macular degeneration from going blind. A colon cancer drug changed all that. But not everyone's vision has been saved.

"You won't believe the price of this one!"

Physician Group Calls On Government To Rein In Drug Prices

3:22pm March 29, 2016

by Alison Kodjak

The American College of Physicians will lobby Congress to allow the re-importation of medicines from other countries and to let Medicare bargain with drugmakers over price. Will lawmakers go along?

Valeant Pharmaceuticals has been the focus of a congressional investigation into high drug prices. .

Drug Company Jacks Up Cost Of Aid-In-Dying Medication

4:57pm March 23, 2016

by April Dembosky

Seconal used to cost less than $200 a bottle. After Valeant Pharmaceuticals bought the medication, the cost rose to $3,000. Advocates for aid in dying say that's a burden for the terminally ill.

Drug-Company Payments Mirror Doctors' Brand-Name Prescribing

9:51am March 17, 2016

An analysis of Medicare data shows that the more money a doctor gets from pharmaceutical companies, the more likely he or she is to prescribe brand-name medications. And that influences cost.

Queue Listen Now